Although inflammatory mediators like IL-22 and IL-17 have different functions in IBD and psoriasis as this is also evident in the targeted treatment response, IL-23 and TNF-α seem to play a crucial part in promoting inflammatory response in both disorders [47]. This evidence concerns the gene TNF and irritable bowel syndrome.